Shares of Mankind Pharma gained 0.71% on November 18, 2024, to trade at Rs 2,616.00, up from the previous close of Rs 2,597.65. This rise translated into a market capitalization increase of approximately Rs 742 crore, bringing the total to Rs 1,04,808.51 crore.
Key Trading Details:
- Traded Volume: 1.10 lakh shares
- Traded Value: Rs 28.78 crore
- VWAP (Volume Weighted Average Price): Rs 2,608.14
- % Deliverable Quantity: 47.63%
Price Highlights:
- 52-Week High: Rs 2,874.00 (06-Nov-2024)
- 52-Week Low: Rs 1,821.00 (14-Dec-2023)
- Upper Band: Rs 3,117.15
- Lower Band: Rs 2,078.15
The uptick in the stock reflects consistent investor confidence in the pharmaceutical sector. The company continues to attract attention for its robust performance and strategic initiatives in the market.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. The author or Business Upturn is not liable for any losses arising from the use of this information.
